Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on β-cell function in normal living conditions

被引：69

作者：

Mari, Andrea

Degn, Kristine

Brock, Birgitte

Rungby, Joergen

Ferrannini, Ele

Schmitz, Ole

机构：

[1] Natl Res Council Inst Biomed Engn, Padua, Italy

[2] Univ Aarhus Hosp, Dept Endocrinol & Diabet, Aarhus, Denmark

[3] Univ Pisa, Natl Res Council Inst Clin Physiol, Pisa, Italy

来源：

DIABETES CARE | 2007年 / 30卷 / 08期

关键词：

D O I：

10.2337/dc07-0310

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2032 / 2033

页数：2

共 7 条

[1] The GLP-1 derivative NN2211 restores β-cell sensitivity to glucose in type 2 diabetic patients after a single dose [J].

Chang, AM ;

Jakobsen, G ;

Sturis, J ;

Smith, MJ ;

Bloem, CJ ;

An, B ;

Galecki, A ;

Halter, JB .

DIABETES, 2003, 52 (07) :1786-1791

[2] One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and α- and β-cell function and reduces endogenous glucose release in patients with type 2 diabetes [J].

Degn, KB ;

Juhl, CB ;

Sturis, J ;

Jakobsen, G ;

Brock, B ;

Chandramouli, V ;

Rungby, J ;

Landau, BR ;

Schmitz, O .

DIABETES, 2004, 53 (05) :1187-1194

[3]

Madsbad S, 2006, DIABETOLOGIA, V49, P4

[4] Mathematical modeling shows exenatide improved β-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea [J].

Mari, A. ;

Nielsen, L. L. ;

Nanayakkara, N. ;

DeFronz, R. A. ;

Ferrannini, E. ;

Halseth, A. .

HORMONE AND METABOLIC RESEARCH, 2006, 38 (12) :838-844

[5] Assessing insulin secretion by modeling in multiple-meal tests - Role of potentiation [J].

Mari, A ;

Tura, A ;

Gastaldelli, A ;

Ferrannini, E .

DIABETES, 2002, 51 :S221-S226

[6] Meal and oral glucose tests for assessment of β-cell function:: modeling analysis in normal subjects [J].

Mari, A ;

Schmitz, O ;

Gastaldelli, A ;

Oestergaard, T ;

Nyholm, B ;

Ferrannini, E .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (06) :E1159-E1166

[7] Glucagon-like peptide 1 and its derivatives in the treatment of diabetes [J].

Nauck, MA ;

Meier, JJ .

REGULATORY PEPTIDES, 2005, 128 (02) :135-148

← 1 →